Kazia Therapeutics Limited
KZIA
$13.16
-$0.67-4.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.32% | -25.10% | -2.12% | 5.63% | 2.75% |
| Total Depreciation and Amortization | -- | -- | 0.00% | -100.07% | -2.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.31% | -48.45% | 2.12% | 223.97% | -2.74% |
| Change in Net Operating Assets | -0.31% | 63.85% | -2.11% | -72.61% | 2.74% |
| Cash from Operations | -0.32% | -100.59% | -2.11% | 44.46% | 2.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 1,313.95% | 0.00% | -54.20% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 756.53% | 0.00% | 97.03% | 0.00% |
| Cash from Financing | 0.32% | 1,132.36% | 2.12% | -38.30% | -2.75% |
| Foreign Exchange rate Adjustments | -0.32% | -557.70% | -2.16% | -213.68% | -2.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.32% | 5,090.35% | 2.14% | -12.35% | -2.74% |